查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1454828

高解析度熔化分析市场：按产品类型、最终用户、地区：全球产业分析、规模、占有率、成长、趋势、预测 2023-2030

High-Resolution Melting Analysis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 201 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了对高解析度熔体分析（High Resolution Melt Analysis）市场的深入分析，全面概述了主要市场趋势、成长动力、挑战和新兴趋势。该报告提供了有关高解析度熔化分析市场结构的宝贵见解，并提供了独特的数据和统计数据来预测 2023 年至 2030 年的市场成长轨迹。

全球高分辨率熔体分析市场预计将以 3.1% 的复合年增长率扩张，从 2023 年的 2.894 亿美元增长到 2030 年底的 3.584 亿美元。

重要见解

  • 高解析度熔化分析市场规模（2023年）：2.894亿美元
  • 预测市场规模（2030年）：3.584亿美元
  • 全球市场成长率（2023-2030年复合年增长率）：3.1%
  • 过去的市场成长率（2018-2022年复合年增长率）：3.0%

高解析度熔化分析市场-调查范围：

高解析度熔解分析市场为核酸序列分析提供了先进的解决方案，为研究人员和临床医生提供了基因分型、突变扫瞄和甲基化分析的准确工具。高解析度熔解分析技术利用DNA熔解曲线的独特性质，以高灵敏度和特异性检测序列变异和遗传异常。市场成长的驱动力是高解析度熔解分析在分子诊断、药物研究和法医分析的广泛应用。高解析度熔解分析具有多功能、准确且经济高效的特点，使其成为不同领域遗传分析的首选方法，从而推动市场扩张。

市场成长动力：

由于遗传疾病、传染病和癌症的盛行率不断增加，对快速可靠的分子诊断技术的需求不断增长，推动了全球高解析度熔解分析市场的发展。与传统方法相比，高解析度熔解分析具有多种优势，包括即时检测、高通量能力以及适用于各种样品类型。此外，高解析度熔解分析仪和软体演算法的进步提高了检测性能，并能够准确检测基因突变、多态性和表观遗传修饰。个人化医疗和精准肿瘤学的日益普及进一步增加了对高解析度熔解分析平台的需求，以促进基因型引导的治疗决策和治疗介入。

市场限制因素：

虽然高解析度熔解分析市场有望显着成长，但它面临着测定标准化、数据解释和替代技术竞争等方面的挑战。标准化不同实验室和仪器的高解析度熔解分析测定是一项技术和后勤挑战，可能会影响测定的重现性和实验室间的一致性。此外，高分辨率熔解分析数据的解释需要曲线分析和生物资讯学方面的专业知识，并且需要专门的培训和软体工具。此外，次世代定序 (NGS) 和数位 PCR (dPCR) 等替代分子诊断技术在定序深度、绝对定量、多重功能等方面提供了互补优势。分辨率为基于熔解分析的检测带来了竞争。

市场机会

全球高解析度熔化分析市场已准备好充分利用精准医疗、伴随诊断和即时检测领域的新商机。随着医疗保健系统转向个人化的疾病管理方法，对快速且经济高效的分子诊断工具的需求不断增加，以帮助指导治疗决策和监测治疗反应。高解析度熔解分析平台在药物基因组学、传染病基因分型和癌症生物标记分析方面具有潜在应用，有助于标靶治疗和伴随诊断测试的开发。此外，高解析度熔解分析系统的小型化和自动化将能够在资源有限的环境中进行分散测试，扩大分子诊断的范围并改善患者的治疗结果。

本报告解决的关键问题

  • 未来哪个地区可望主导高解析度熔化分析市场？
  • 推动在分子诊断和研究应用中采用高解析度熔解分析技术的主要因素是什么？
  • 持续的技术进步和监管发展将如何影响全球高解析度熔化分析市场？
  • 谁是高解析度熔化分析市场的主要参与者？他们采取什么策略来获得竞争优势？
  • 塑造高解析度熔化分析市场的关键应用领域和新兴趋势有哪些？

竞争状况及经营策略：

全球高解析度熔解分析市场的主要参与者，如 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc. 和 QIAGEN NV，优先考虑创新和策略合作伙伴关係，以维持其市场领先地位。这些公司在研发方面投入巨资，以提高其高分辨率熔解分析仪的性能、开发新的检测化学物质并扩展其检测菜单。此外，与学术机构、临床实验室和製药公司的策略联盟使企业能够验证特定应用的高解析度熔解分析测定，扩大市场范围并加速技术采用。透过利用其技术专长、全球分销网络和监管环境，市场领导者能够利用新的商机并响应动态分子诊断行业不断变化的客户需求。

主要公司简介

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffman-La Roche Ltd.
  • Bio Farma
  • QIAGEN
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • BIOMERIEUX
  • Meridian Bioscience, Inc.
  • Novacyt
  • PREMIER Biosoft
  • Azura Genomics Inc.
  • Canon Medical Systems Corporation

高解析度熔化分析市场研究细分：

高解析度熔化分析市场根据产品类型、应用、最终用户和地区等各种参数进行细分。

按产品

  • 试剂
  • 机器
  • 软件

按用途

  • 获得性突变检测/突变扫瞄/SNP分型
  • 微生物种类的鑑定
  • 接合性测试
  • 表观遗传学/甲基化分析与抗药性

由最终用户

  • 学术研究
  • 临床诊断

按地区

  • 北美
  • 欧洲
  • 东亚
  • 南亚/大洋洲
  • 拉丁美洲
  • 中东/非洲

目录

第一章内容提要

第二章市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 产品生命週期分析
  • 高解析度熔体分析市场：价值链
    • 原材料供应商名单
    • 製造商名单
    • 经销商名单
    • 用途一览
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界GDP成长率展望
    • 全球母公司市场概览
  • 预测变量 - 相关性和影响
  • 监管和技术格局

第三章全球高解析度熔融分析市场展望：过去（2018-2022）与预测（2023-2030）

    • 市场数量（件）预测
    • 市场规模及年成长率
    • 绝对数量的机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2013-2016
    • 目前市场规模预测，2018-2026
  • 全球高解析度熔体分析市场展望：产品
    • 简介/主要发现
    • 2018-2022 年过去的市场规模（百万美元）和数量（件）分析：按产品
    • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
      • 试剂
      • 机器
      • 软件
  • 市场吸引力分析：产品
  • 全球高解析度熔体分析市场展望：最终用户
    • 简介/主要发现
    • 2018-2022 年过去的市场规模（百万美元）和数量（件）分析：按最终用户
    • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
      • 学术研究
      • 临床诊断
  • 市场吸引力分析：最终用户
  • 全球高解析度熔化分析市场展望：应用
    • 简介/主要发现
    • 2018-2022 年过去的市场规模（百万美元）和数量（件）分析：按应用分类
    • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
      • 获得性突变检测/突变扫瞄/SNP分型
      • 微生物种类的鑑定
      • 接合性测试
      • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析：应用

第四章全球高解析度熔化分析市场展望：地区

  • 2018-2022 年历史市场规模（百万美元）和数量（件）分析：按地区
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东/非洲
  • 市场吸引力分析：区域

第五章北美高解析度熔化分析市场展望：过去（2018-2022）与预测（2023-2030）

  • 价格分析
  • 过去的市场规模（百万美元）和数量（件）分析，2018-2022：按市场
    • 按国家
    • 按产品
    • 按最终用户
    • 按用途
  • 2023-2030 年当前市场规模（百万美元）和数量（单位）预测：按国家分类
    • 美国
    • 加拿大
  • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
    • 试剂
    • 机器
    • 软件
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
    • 学术研究
    • 临床诊断
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
    • 获得性突变检测/突变扫瞄/SNP分型
    • 微生物种类的鑑定
    • 接合性测试
    • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析

第六章欧洲高解析度熔化分析市场展望：过去（2018-2022）与预测（2023-2030）

  • 价格分析
  • 过去的市场规模（百万美元）和数量（件）分析，2018-2022：按市场
    • 按国家
    • 按产品
    • 按最终用户
    • 按用途
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按国家分类
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 土耳其
    • 欧洲其他地区
  • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
    • 试剂
    • 机器
    • 软件
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
    • 学术研究
    • 临床诊断
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
    • 获得性突变检测/突变扫瞄/SNP分型
    • 微生物种类的鑑定
    • 接合性测试
    • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析

第七章东亚高解析度熔融分析市场展望：过去（2018-2022）与预测（2023-2030）

  • 价格分析
  • 过去的市场规模（百万美元）和数量（件）分析，2018-2022：按市场
    • 按国家
    • 按产品
    • 按最终用户
    • 按用途
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按国家分类
    • 中国
    • 日本
    • 韩国
  • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
    • 试剂
    • 机器
    • 软件
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
    • 学术研究
    • 临床诊断
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
    • 获得性突变检测/突变扫瞄/SNP分型
    • 微生物种类的鑑定
    • 接合性测试
    • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析

第 8 章 南亚和大洋洲高分辨率熔体分析市场展望：过去（2018-2022）和预测（2023-2030）

  • 价格分析
  • 过去的市场规模（百万美元）和数量（件）分析，2018-2022：按市场
    • 按国家
    • 按产品
    • 按最终用户
    • 按用途
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按国家分类
    • 印度
    • 东南亚
    • 纽西兰
    • 南亚和大洋洲其他地区
  • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
    • 试剂
    • 机器
    • 软件
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
    • 学术研究
    • 临床诊断
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
    • 获得性突变检测/突变扫瞄/SNP分型
    • 微生物种类的鑑定
    • 接合性测试
    • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析

第9章拉丁美洲高解析度熔融分析市场展望：过去（2018-2022）与预测（2023-2030）

  • 价格分析
  • 2018-2022 年按市场划分的过往市场规模（百万美元）和数量（单位）分析
    • 按国家
    • 按产品
    • 按最终用户
    • 按用途
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按国家分类
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
    • 试剂
    • 机器
    • 软件
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
    • 学术研究
    • 临床诊断
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
    • 获得性突变检测/突变扫瞄/SNP分型
    • 微生物种类的鑑定
    • 接合性测试
    • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析

第10章中东和非洲高分辨率熔体分析市场展望：过去（2018-2022）和预测（2023-2030）

  • 价格分析
  • 过去的市场规模（百万美元）和数量（件）分析，2018-2022：按市场
    • 按国家
    • 按产品
    • 按最终用户
    • 按用途
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按国家分类
    • 海湾合作委员会国家
    • 埃及
    • 南非
    • 北非
    • 其他中东/非洲
  • 2023-2030 年当前市场规模（百万美元）及销售量（单位）预测：依产品
    • 试剂
    • 机器
    • 软件
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按最终用户划分
    • 学术研究
    • 临床诊断
  • 2023-2030 年当前市场规模（百万美元）和销售（单位）预测：按应用分类
    • 获得性突变检测/突变扫瞄/SNP分型
    • 微生物种类的鑑定
    • 接合性测试
    • 表观遗传学/甲基化分析与抗药性
  • 市场吸引力分析

第十一章竞争格局

  • 2022 年市场占有率分析
  • 市场结构
    • 按市场划分的竞争强度图
    • 有竞争力的模拟IC
    • 表观产品容量
  • 公司简介（详细资讯 - 概述、财务、策略、近期发展）
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffman-La Roche Ltd.
    • Bio Farma
    • QIAGEN
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • BIOMERIEUX
    • Meridian Bioscience, Inc.
    • Novacyt
    • PREMIER Biosoft
    • Azura Genomics Inc.
    • Canon Medical Systems Corporation

第十二章附录

  • 调查方法
  • 调查假设
  • 缩写
简介目录
Product Code: PMRREP33995

Persistence Market Research has recently released an in-depth analysis of the High-Resolution Melting Analysis (HRMA) Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the structure of the HRMA market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The global high-resolution melting analysis market is forecast to expand at a CAGR of 3.1% and thereby increase from US$289.4 Mn in 2023, to US$358.4 Mn by the end of 2030.

Key Insights:

  • HRMA Market Size (2023E): USD 289.4 Million
  • Projected Market Value (2030F): US$ 358.4 Million
  • Global Market Growth Rate (CAGR 2023 to 2030): 3.1%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 3.0%

HRMA Market - Report Scope:

The HRMA market offers advanced solutions for the analysis of nucleic acid sequences, providing researchers and clinicians with precise tools for genotyping, mutation scanning, and methylation analysis. HRMA technology leverages the unique properties of DNA melting curves to detect sequence variations and genetic abnormalities with high sensitivity and specificity. Market growth is driven by the expanding applications of HRMA in molecular diagnostics, pharmaceutical research, and forensic analysis. The versatility, accuracy, and cost-effectiveness of HRMA make it a preferred choice for genetic analysis across diverse fields, fueling market expansion.

Market Growth Drivers:

The global HRMA market is propelled by the increasing prevalence of genetic disorders, infectious diseases, and cancer, driving demand for rapid and reliable molecular diagnostic techniques. HRMA offers several advantages over traditional methods, including real-time detection, high-throughput capabilities, and compatibility with various sample types. Additionally, advancements in HRMA instrumentation and software algorithms enhance assay performance, enabling accurate detection of genetic mutations, polymorphisms, and epigenetic modifications. The growing adoption of personalized medicine and precision oncology further augments the demand for HRMA platforms, facilitating genotype-guided treatment decisions and therapeutic interventions.

Market Restraints:

Despite significant growth prospects, the HRMA market faces challenges related to assay standardization, data interpretation, and competition from alternative technologies. Standardizing HRMA assays across different laboratories and instruments poses technical and logistical challenges, potentially affecting assay reproducibility and inter-laboratory consistency. Moreover, interpreting HRMA data requires expertise in curve analysis and bioinformatics, necessitating specialized training and software tools. Additionally, alternative molecular diagnostic techniques, such as next-generation sequencing (NGS) and digital PCR (dPCR), offer complementary advantages in terms of sequencing depth, absolute quantification, and multiplexing capabilities, posing competition for HRMA-based assays.

Market Opportunities:

The global HRMA market stands poised to capitalize on emerging opportunities in precision medicine, companion diagnostics, and point-of-care testing. As healthcare systems shift towards personalized approaches to disease management, there is an increasing demand for rapid and cost-effective molecular diagnostic tools that can guide treatment decisions and monitor therapeutic responses. HRMA platforms offer potential applications in pharmacogenomics, infectious disease genotyping, and cancer biomarker analysis, facilitating the development of targeted therapies and companion diagnostic tests. Moreover, the miniaturization and automation of HRMA systems enable decentralized testing in resource-limited settings, expanding access to molecular diagnostics and improving patient outcomes.

Key Questions Answered in the Report:

  • Which regions are expected to dominate the HRMA market in the future?
  • What are the primary factors driving the adoption of HRMA technology in molecular diagnostics and research applications?
  • How will ongoing technological advancements and regulatory developments impact the global HRMA market?
  • Who are the key players contributing to the HRMA market, and what strategies are they employing to gain a competitive edge?
  • What are the key application areas and emerging trends shaping the landscape of the HRMA market?

Competitive Landscape and Business Strategy:

Major players in the global HRMA market, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and QIAGEN N.V., prioritize innovation and strategic partnerships to maintain market leadership. These companies invest significantly in research and development to enhance HRMA instrument performance, develop novel assay chemistries, and expand assay menus. Furthermore, strategic collaborations with academic institutions, clinical laboratories, and pharmaceutical companies enable market players to validate HRMA assays for specific applications, broaden market reach, and foster technology adoption. By leveraging their technological expertise, global distribution networks, and regulatory capabilities, market leaders can capitalize on emerging opportunities and address evolving customer needs in the dynamic molecular diagnostics landscape.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffman-La Roche Ltd.
  • Bio Farma
  • QIAGEN
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • BIOMERIEUX
  • Meridian Bioscience, Inc.
  • Novacyt
  • PREMIER Biosoft
  • Azura Genomics Inc.
  • Canon Medical Systems Corporation

HRMA Market Research Segmentation:

The HRMA market is segmented based on various parameters, including product type, application, end-user, and region.

By Product:

  • Reagents
  • Instruments
  • Software

By Application:

  • Detection of Acquired Mutations/Mutation Scanning/SNP Typing
  • Microbial Species Identification
  • Zygosity Testing
  • Epigenetics/Methylation Profiling and Drug-Resistant

By End User:

  • Academic Research
  • Clinical Diagnostics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global High-Resolution Melting Analysis Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. High-Resolution Melting Analysis Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global High-Resolution Melting Analysis Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Reagents
      • 3.3.3.2. Instruments
      • 3.3.3.3. Software
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global High-Resolution Melting Analysis Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Academic Research
      • 3.5.3.2. Clinical Diagnostics
  • 3.6. Market Attractiveness Analysis: End User
  • 3.7. Global High-Resolution Melting Analysis Market Outlook: Application
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
      • 3.7.3.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
      • 3.7.3.2. Microbial Species Identification
      • 3.7.3.3. Zygosity Testing
      • 3.7.3.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 3.8. Market Attractiveness Analysis: Application

4. Global High-Resolution Melting Analysis Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By End User
    • 5.3.4. By Application
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Reagents
    • 5.5.2. Instruments
    • 5.5.3. Software
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Academic Research
    • 5.6.2. Clinical Diagnostics
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 5.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
    • 5.7.2. Microbial Species Identification
    • 5.7.3. Zygosity Testing
    • 5.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 5.8. Market Attractiveness Analysis

6. Europe High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By End User
    • 6.3.4. By Application
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Reagents
    • 6.5.2. Instruments
    • 6.5.3. Software
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Academic Research
    • 6.6.2. Clinical Diagnostics
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 6.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
    • 6.7.2. Microbial Species Identification
    • 6.7.3. Zygosity Testing
    • 6.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 6.8. Market Attractiveness Analysis

7. East Asia High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By End User
    • 7.3.4. By Application
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Reagents
    • 7.5.2. Instruments
    • 7.5.3. Software
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Academic Research
    • 7.6.2. Clinical Diagnostics
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 7.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
    • 7.7.2. Microbial Species Identification
    • 7.7.3. Zygosity Testing
    • 7.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By End User
    • 8.3.4. By Application
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Reagents
    • 8.5.2. Instruments
    • 8.5.3. Software
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Academic Research
    • 8.6.2. Clinical Diagnostics
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 8.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
    • 8.7.2. Microbial Species Identification
    • 8.7.3. Zygosity Testing
    • 8.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 8.8. Market Attractiveness Analysis

9. Latin America High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis ByMarket, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By End User
    • 9.3.4. By Application
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Reagents
    • 9.5.2. Instruments
    • 9.5.3. Software
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Academic Research
    • 9.6.2. Clinical Diagnostics
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 9.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
    • 9.7.2. Microbial Species Identification
    • 9.7.3. Zygosity Testing
    • 9.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa High-Resolution Melting Analysis Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By End User
    • 10.3.4. By Application
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Reagents
    • 10.5.2. Instruments
    • 10.5.3. Software
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Academic Research
    • 10.6.2. Clinical Diagnostics
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 10.7.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
    • 10.7.2. Microbial Species Identification
    • 10.7.3. Zygosity Testing
    • 10.7.4. Epigenetics/Methylation Profiling and Drug-Resistant
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Thermo Fisher Scientific Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Bio-Rad Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. F. Hoffman-La Roche Ltd.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Bio Farma
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. QIAGEN
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Illumina, Inc.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Agilent Technologies, Inc.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. BIOMERIEUX
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Meridian Bioscience, Inc.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Novacyt
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. PREMIER Biosoft
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. Azura Genomics Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Canon Medical Systems Corporation
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations